OQS
RCKT icon

Occudo Quantitative Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History

Occudo Quantitative Strategies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-184,658
Closed -$452K – 838
2025
Q2 		$452K Buy
+184,658
New +$935K 0.05% 367
2023
Q3 		– Sell
-10,702
Closed -$213K – 1255
2023
Q2 		$213K Sell
10,702
-12,785
-54% -$258K 0.02% 837
2023
Q1 		$402K Buy
+23,487
New +$460K 0.04% 572
2022
Q4 		– Sell
-34,397
Closed -$549K – 1302
2022
Q3 		$549K Buy
34,397
+16,483
+92% +$257K 0.04% 628
2022
Q2 		$246K Sell
17,914
-3,433
-16% -$40.9K 0.02% 849
2022
Q1 		$339K Buy
21,347
+7,921
+59% +$137K 0.03% 777
2021
Q4 		$293K Buy
13,426
+259
+2% +$7.07K 0.03% 777
2021
Q3 		$394K Buy
13,167
+2,522
+24% +$91.8K 0.05% 627
2021
Q2 		$471K Buy
10,645
+1,909
+22% +$82.9K 0.07% 448
2021
Q1 		$388K Buy
+8,736
New +$480K 0.08% 415

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return